Literature DB >> 20495162

Heterogeneity in the pharmacological treatment of children with ADHD: cognitive, behavioral, and social functioning differences.

Paulo A Graziano1, Gary R Geffken, Ayesha S Lall.   

Abstract

OBJECTIVE: To investigate the extent to which children with ADHD in various medication statuses (i.e., medication naïve, pure stimulant, stimulant plus another medication, nonstimulants) varied on cognitive or academic, behavioral, and social functioning during a psychoeducational assessment battery.
METHOD: Participants for this study consisted of 66 children (20 girls) with a Diagnostic and Statistical Manual of Mental Disorders (4th ed.) (DSM-IV) diagnosis of ADHD confirmed by a comprehensive clinical diagnostic assessment, including the use of a semistructured interview and Conners' Parent Rating Scales. Standardized cognitive and academic measures along with parent report of medication status, behavioral, and social functioning were collected.
RESULTS: No differences were found among children in the various medication groups in terms of ADHD symptoms severity, academic performance, processing speed, verbal abilities, or perceptual reasoning skills. However, children in the medication-naïve group performed significantly better than the stimulant-plus-another-medication and nonstimulant groups in terms of overall cognitive abilities, working-memory skills, and social adaptability but had similar scores to children in the pure-stimulant group. Children in the pure-stimulant group also had marginally higher working-memory scores compared to children in the nonstimulant group but not compared to the stimulant-plus-another-medication group. The pure-stimulant group also had significantly lower externalizing and internalizing problems and higher social adaptability compared to the stimulant-plus-another-medication group but not compared to the medication-naïve or nonstimulant groups.
CONCLUSION: Findings showed evidence for distinct cognitive, behavioral, and social profiles among children with ADHD who are proactively not on medication, as well as differences among children with ADHD who are on only one stimulant versus a nonstimulant or stimulant-plus-another-medication regimen.
© 2011 SAGE Publications

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20495162     DOI: 10.1177/1087054710367772

Source DB:  PubMed          Journal:  J Atten Disord        ISSN: 1087-0547            Impact factor:   3.256


  5 in total

1.  Processing Speed Predicts Behavioral Treatment Outcomes in Children with Attention-Deficit/Hyperactivity Disorder Predominantly Inattentive Type.

Authors:  Christopher J Adalio; Elizabeth B Owens; Keith McBurnett; Stephen P Hinshaw; Linda J Pfiffner
Journal:  J Abnorm Child Psychol       Date:  2018-05

2.  Parent Perceptions of Medication Treatment for Preschool Children with ADHD.

Authors:  Katie C Hart; Rosmary Ros; Victoria Gonzalez; Paulo A Graziano
Journal:  Child Psychiatry Hum Dev       Date:  2018-02

3.  Group membership prediction when known groups consist of unknown subgroups: a Monte Carlo comparison of methods.

Authors:  W Holmes Finch; Jocelyn H Bolin; Ken Kelley
Journal:  Front Psychol       Date:  2014-05-20

4.  Examining the Effect of Transcranial Electrical Stimulation and Cognitive Training on Processing Speed in Pediatric Attention Deficit Hyperactivity Disorder: A Pilot Study.

Authors:  Ornella Dakwar-Kawar; Itai Berger; Snir Barzilay; Ephraim S Grossman; Roi Cohen Kadosh; Mor Nahum
Journal:  Front Hum Neurosci       Date:  2022-07-27       Impact factor: 3.473

5.  Behavioral Outcome Effects of Serious Gaming as an Adjunct to Treatment for Children With Attention-Deficit/Hyperactivity Disorder: A Randomized Controlled Trial.

Authors:  Kim C M Bul; Pamela M Kato; Saskia Van der Oord; Marina Danckaerts; Leonie J Vreeke; Annik Willems; Helga J J van Oers; Ria Van Den Heuvel; Derk Birnie; Thérèse A M J Van Amelsvoort; Ingmar H A Franken; Athanasios Maras
Journal:  J Med Internet Res       Date:  2016-02-16       Impact factor: 5.428

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.